Changes in Chromogranin A Serum Levels During Endocrine Therapy in Metastatic Prostate Cancer Patients

During endocrine therapy in metastatic prostate cancer patients, serum CGA values were not related to serum PSA levels, and increased as treatment periods became longer. It is suggested that CGA velocity has potential to predict androgen independent progression after endocrine therapy.